In BC tissues, miR-340-5p expression is reduced, which is closely associated with the clinicopathological indicators of patients, and inhibiting miR-340-5p expression helps stabilize ZEB2 protein level and promote the metastasis of BC cells [34]. Here, ZEB2 is linked to breast cancer.